Tiziana Life regains compliance with Nasdaq listing minimum bid price rule

Tiziana Life Sciences announces that it has received a notification from the Nasdaq Stock Market Listing Qualifications Department informing the Company that it has regained compliance with the Nasdaq listing minimum bid price requirement for continued listing on the Nasdaq Capital Market exchange. Tiziana was previously notified by Nasdaq on June 14, 2022 that it was not in compliance with the minimum bid-price listing rule because its common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive business days. To regain compliance, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least ten consecutive trading days which was met on April 20, 2023.